ESG

U Power (UCAR) presents its AI-driven energy grid strategy at a key conference, betting on a tech pivot to reignite investor interest after a steep decline.

Rising repair costs and market volatility are forcing homeowners to rethink their selling strategy, seeking certainty over a potential bidding war.

A new partnership signals a major shift in the art market, placing scientific conservation at the heart of determining an asset's long-term value.

The inaugural MICHELIN Guide Saudi Arabia 2026 has landed, recognizing 51 restaurants and heralding the Kingdom's arrival as a global gastronomic force.

Swedish mining giant Boliden lands a massive €1 billion credit line, signaling strong bank confidence and fueling its expansion after a landmark year.

UGG's Spring 2026 campaign, fronted by global icons Central Cee and Su Yiming, introduces new clogs and mules in a bold move to redefine menswear.

A new ETF, EXEQ, uses AI to score and invest in corporate leadership, aiming to turn a qualitative trait into a data-driven source of returns.

Iterum Therapeutics secures key Medicare access for its antibiotic ORLYNVAH™, but a costly FDA trial requirement for a new use casts a shadow on its future.

The pipeline giant's record $20B EBITDA is fueled by traditional energy, while it aggressively expands into renewables to power the digital economy.

STADA and Bio-Thera's new golimumab biosimilar wins European approval, promising to slash healthcare costs and expand treatment access for millions.

Byreal's 2026 roadmap, revealed at Solana Accelerate, promises AI-driven liquidity and 24/7 real-world asset trading, aiming to woo institutions.

A new 'Wuthering Heights' film arrives, but its true story may be its surprising link to the global phenomenon of the telenovela. How did it happen?

Vibrant festivals in Cairo and Rabat celebrate the Chinese New Year, revealing a strategic cultural diplomacy effort to deepen ties in the Middle East.

Helion's Polaris prototype achieves a private industry first with 150M°C plasma and D-T fusion, accelerating its plan to power Microsoft by 2028.

Aktiia's Hilo adds sleep and step tracking to its validated blood pressure monitor, promising a holistic view of heart health in a competitive market.

As Guardian Pharmacy Services prepares for a key investor conference, it showcases strong growth while its industry faces a looming crisis. Can its model work?

As the Milan 2026 Winter Events begin, a massive new e-bike fleet and an affordable 'Champion Pass' aim to redefine sustainable urban mobility.

After its lead anxiety drug failed a key trial, Vistagen turns to AI and a new menopause treatment to secure its future. Can the company recover?

Appili Therapeutics lands a $40M deal to fight fungal threats, but with cash reserves low and loans due, can its science outpace its financial pressures?

Vitalist reports soaring losses and a $6.4M debt surge, raising 'going concern' alarms. Can its new Reebok smartwatches and VitalOS™ platform save it?